The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 11, 2014

Filed:

Nov. 27, 2012
Applicant:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Inventors:

El Bachir Kaloun, Roquettes, FR;

Karim Bedjeguelal, Toulouse, FR;

Rémi Rabot, Toulouse, FR;

Anna Kruczynski, Pompertuzat, FR;

Philippe Schmitt, Nailloux, FR;

Michel Perez, Castres, FR;

Nicolas Rahier, Ayguesvives, FR;

Assignee:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); C07D 401/00 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); C07D 471/04 (2006.01); A61K 45/06 (2006.01); A61K 31/4545 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/496 (2013.01); A61K 31/437 (2013.01); A61K 31/4985 (2013.01); A61K 45/06 (2013.01); A61K 31/4545 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.


Find Patent Forward Citations

Loading…